Bortezomib Induced Hepatitis B Reactivation

Bortezomib Induced Hepatitis B Reactivation

Background. It has recently been reported that hepatitis B (HBV) reactivation often occurs after the use of rituximab and stem cell transplantation in patients with lymphoma who are hepatitis B surface antigen (HBsAg) negative. However, clinical data on HBV reactivation in multiple myeloma (MM) is l...

Full description

Bibliographic Details
Main Authors:	Salwa Hussain, Ruby Jhaj, Samira Ahsan, Muhammad Ahsan, Robert E. Bloom, Syed-Mohammed R. Jafri
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Case Reports in Medicine
Online Access:	http://dx.doi.org/10.1155/2014/964082

Similar Items

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
by: Syed M. Hasan MD, et al.
Published: (2018-03-01)

An Overview of Bortezomib-Induced Neurotoxicity
by: Cristina Meregalli
Published: (2015-07-01)

Array signal processing based on traditional and sparse arrays
by: Jafri, Ahsan
Published: (2019)

Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study
by: Jin Lu, et al.
Published: (2016-01-01)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
by: N. O’Connor-Byrne, et al.
Published: (2019-02-01)

Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: E. Vandeix, et al.
Published: (2012-01-01)

Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Supramolecular Caffeic Acid and Bortezomib Nanomedicine: Prodrug Inducing Reactive Oxygen Species and Inhibiting Cancer Cell Survival
by: Ludwig Erik Aguilar, et al.
Published: (2020-11-01)

Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01)

Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced down regulation of Akt
by: Ahsan Md.Kaimul
Published: (2011)

A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B
by: Anita Pandey, et al.
Published: (2018-01-01)

The chemotherapeutic agent bortezomib induces the formation of stress granules
by: Gareau Cristina, et al.
Published: (2010-04-01)

The protective effects of lafutidine for bortezomib induced peripheral neuropathy
by: Tsukaguchi M, et al.
Published: (2013-07-01)

Bortezomib in Kidney Transplantation
by: Rajeev Raghavan, et al.
Published: (2010-01-01)

Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
by: Jeter Ashley, et al.
Published: (2012-08-01)

Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats
by: Shota Yamamoto, et al.
Published: (2015-09-01)

The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy
by: Wenping Yan, et al.
Published: (2021-10-01)

The Study of Hepatitis B Virus Reactivation
by: Chi Zhao-chun
Published: (2014-12-01)

Bortezomib in the management of multiple myeloma
by: Jacob P Laubach, et al.
Published: (2009-09-01)

TREATMENT OF MULTIPLE MYELOMA WITH BORTEZOMIB
by: Veronika Kodre, et al.
Published: (2008-04-01)

Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia
by: Ibrahim N. Muhsen, et al.
Published: (2020-12-01)

Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia
by: Ingrid M. Wirth, et al.
Published: (2020-01-01)

Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells.
by: Bulbul Pandit, et al.
Published: (2011-02-01)

BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma.
by: Sara Busacca, et al.
Published: (2013-01-01)

Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy
by: Marcelle G. Meseeha, et al.
Published: (2015-12-01)

Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
by: Prakash Kharel, et al.
Published: (2018-01-01)

RELATIVE FREQUENCY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTIONS IN PATIENTS OF LIVER CIRRHOSIS IN CHILDREN
by: Syed Nizam Hussain Shah, et al.
Published: (2020-02-01)

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells.
by: Li Jia, et al.
Published: (2012-01-01)

HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2
by: Heike Härtel, et al.
Published: (2021-01-01)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
by: Venessa Pattullo
Published: (2016-06-01)

Research advances in hepatitis B virus reactivation
by: LI Mengyuan, et al.
Published: (2017-04-01)

Histopathological features of chronic hepatitis B reactivation
by: Remzi Bestas, et al.
Published: (2020-09-01)

Reactive oxygen species: role in the development of cancer and various chronic conditions
by: Waris Gulam, et al.
Published: (2006-05-01)

An unusual complication of bortezomib therapy: Acute pancreatitis
by: H Gupta, et al.
Published: (2014-01-01)

Leukocytoclastic Vasculitis Associated with Bortezomib Therapy
by: Thiagarajan Raj Yashwanth, et al.
Published: (2020-01-01)

Clinical manifestations of intravitreal bortezomib injection
by: Chan Nguyen, et al.
Published: (2020-12-01)

Development and characterization of liposomal formulation of bortezomib
by: Anil K. Deshantri, et al.
Published: (2019-12-01)

Bortezomib for the treatment of multiple myeloma patients
by: Green, Colin, et al.
Published: (2009)

Bortezomib for the treatment of multiple myeloma patients
by: C Green, et al.
Published: (2009-06-01)

Why bortezomib cannot go with ‘green’?
by: Li Jia, et al.
Published: (2013-12-01)